S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48%

S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48%

Next Bullish Trade

Sign in

Account

Create free accountFree dashboard, no payment Sign inEmail yourself a login link CoursesYour library & catalog

IRON

Disc Medicine, Inc. IRON

$76.15 +2.68 (+3.65%)

Neutral · +0.47σ

+ Compare Open in Sniper

News · IRON

Full news feed →

Putnam Investor News: If You Have Suffered Losses in Putnam Investment Management LLC, You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire Inc. · 3d ago

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Embecta Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EMBC

GlobeNewswire Inc. · 20d ago

Polycythemia Vera Market Set for Transformation: Key 9 Companies Expected to Enter by 2036 | DelveInsight

GlobeNewswire Inc. · 87d ago

Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire Inc. · 88d ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON

GlobeNewswire Inc. · 102d ago

Disc Medicine, Inc. Investigated by the Portnoy Law Firm

GlobeNewswire Inc. · 113d ago